Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment patterns of symptomatic treatments for Alzheimer's disease and related dementias.

BMC geriatrics·2025
Same author

Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development.

Frontiers in immunology·2023
Same author

Adherence and persistence of HIV pre-exposure prophylaxis use in the United States.

Pharmacoepidemiology and drug safety·2023
Same author

Trends of nonoccupational postexposure prophylaxis in the United States.

AIDS (London, England)·2023
Same author

Adherence to HIV Pre-Exposure Prophylaxis Testing Guidelines in the United States.

AIDS patient care and STDs·2023
Same author

Design of Customized Mobile Application for Patient Adherence to Oral Anticancer Medications Utilizing User-Centered Design.

The Journal of biocommunication·2022

Related Experiment Video

Updated: Jun 25, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

Pharmacists' considerations when serving Amish patients.

Stephanie Y Crawford1, Aimée M Manuel, Bruce D Wood

  • 1Department of Pharmacy Administration, College of Pharmacy, Universityof Illinois at Chicago, IL 60612, USA. crawford@uic.edu

Journal of the American Pharmacists Association : Japha
|February 7, 2009
PubMed
Summary

Pharmacists should understand Amish culture and beliefs to provide patient-centered care. Tailoring services to individual needs and addressing barriers like language and cost improves health outcomes for the Amish community.

More Related Videos

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Experiment Videos

Last Updated: Jun 25, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Area of Science:

  • Sociology of health
  • Cultural competency in healthcare
  • Pharmacy practice

Background:

  • The Old Order Amish are a religious group with distinct health beliefs and decision-making processes.
  • Amish communities value health and actively participate in healthcare choices, often influenced by community and family.
  • Their understanding of health and illness may differ from mainstream American society, incorporating folk and alternative medicine alongside conventional care.

Purpose of the Study:

  • To explore historical and sociocultural factors influencing Amish health decisions.
  • To describe the role of pharmacists in providing culturally and linguistically appropriate care to Amish populations.
  • To highlight culturally competent pharmacy practices for serving diverse communities.

Main Methods:

  • A community independent pharmacy in Arthur, IL, serving a significant Amish population from 1991 to 2008.
  • Reflections and practice insights from a pharmacist-owner.
  • Analysis of Amish cultural norms, beliefs, and healthcare-seeking behaviors.

Main Results:

  • Cultural awareness is crucial, but stereotyping must be avoided due to variations across Amish districts.
  • Individualized care is essential, considering specific cultural aspects and patient needs.
  • Barriers to care include unique dialects, affordability for cash-paying patients, lower prenatal care utilization, and reduced vaccination rates.

Conclusions:

  • Increased awareness and sensitivity to Amish lifestyles improve patient-centered pharmacy care.
  • Building trust and working within community norms are key to effective care.
  • Applying cultural competency techniques helps pharmacists overcome barriers and optimize services for Amish patients.